MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jacob Stroh, Anja Seckinger, Michael Heider, Martina Rudelius, Ruth Eichner, Markus Schick, Jolanta Slawska, Martina Emde-Rajaratnam, Hans Salwender, Uta Bertsch, Hartmut Goldschmidt, Katja Weisel, Christof Scheid, Ulrich Keller, Dirk Hose, Florian Bassermann

Journal title: Blood Advances

Journal number: 24739537

Journal publisher: Elsevier

Published year: 2022

DOI identifier: 10.1182/bloodadvances.2021005532

ISSN: 2473-9537